Prazosin
- Product NDC
- 0527-4182
- 11-digit product format
- 005274182
- Labeler code
- 0527
- Product ID
- 0527-4182_41beba09-90c1-42cc-bfba-ac8a84d09649
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Prazosin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Lannett Company, Inc.
- Application
- ANDA214083
- Marketing category
- ANDA
- Marketing start
- 2024-01-03
- Substance
- PRAZOSIN HYDROCHLORIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| X0Z7454B90 | PRAZOSIN HYDROCHLORIDE | 19237-84-4 | PRAZOSIN HYDROCHLORIDE |
| XM03YJ541D | PRAZOSIN | 19216-56-9 | Prazosin |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 0527-4182-37 | 00527418237 | 100 CAPSULE in 1 BOTTLE (0527-4182-37) | 100 capsule | 2024-01-03 | No | No | Historical |
| 0527-4182-42 | 00527418242 | 250 CAPSULE in 1 BOTTLE (0527-4182-42) | 250 capsule | 2024-01-03 | No | No | Historical |